IMMUNATE

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Estonia, Finland, Hong Kong SAR China, Lithuania, Malta, Poland, Romania, South Africa, Tunisia, Turkey.

Active ingredients

The drug IMMUNATE contains one active pharmaceutical ingredient (API):

1
UNII 5T6B772R4Q - HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX
 

Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X (factor Xa). Haemophilia A is a sex-linked hereditary disorder of blood coagulation due to decreased levels of factor VIII:C. By replacement therapy the plasma levels of factor VIII are increased, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies.

 
Read more about Coagulation factor VIII

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B02BD04 Coagulation factor IX B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD04
B02BD06 Von Willebrand factor and coagulation factor VIII in combination B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 501121010034417, 501121010034517, 501121010034617
EE Ravimiamet 1038079, 1038091, 1349232
FI Lääkealan turvallisuus- ja kehittämiskeskus 541183
HK Department of Health Drug Office 57835, 58390
HR Agencija za lijekove i medicinske proizvode HR-H-927359696
LT Valstybinė vaistų kontrolės tarnyba 1004579, 1004580, 1004581
MT Medicines Authority MA162/00701, MA162/00702, MA162/00703
PL Rejestru Produktów Leczniczych 100160309, 100160315, 100160338
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W62886001, W62887001, W62888001
TN Direction de la Pharmacie et du Médicament 10623021H, 10623022H
TR İlaç ve Tıbbi Cihaz Kurumu 8681429550134, 8681429550141
ZA Health Products Regulatory Authority A40/30.3/0215, A40/30.3/0216, A40/30.3/0217

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.